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Abstract
Background: Our understanding of the transmission dynamics of respiratory syncytial virus (RSV) infection will be
better informed with improved data on the patterns of shedding in cases not limited only to hospital admissions.
Methods: In a household study, children testing RSV positive by direct immunofluorescent antibody test (DFA)
were enrolled. Nasal washings were scheduled right away, then every three days until day 14, every 7 days until
day 28 and every 2 weeks until a maximum of 16 weeks, or until the first DFA negative RSV specimen. The
relationship between host factors, illness severity and viral shedding was investigated using Cox regression
methods.
Results: From 151 families a total of 193 children were enrolled with a median age of 21 months (range 1-164
months), 10% infants and 46% male. The rate of recovery from infection was 0.22/person/day (95% CI 0.19-0.25)
equivalent to a mean duration of shedding of 4.5 days (95%CI 4.0-5.3), with a median duration of shedding of 4
days (IQR 2-6, range 1-14). Children with a history of RSV infection had a 40% increased rate of recovery i.e. shorter
duration of viral shedding (hazard ratio 1.4, 95% CI 1.01-1.86). The rate of cessation of shedding did not differ
significantly between males and females, by severity of infection or by age.
Conclusion: We provide evidence of a relationship between the duration of shedding and history of infection,
which may have a bearing on the relative role of primary versus re-infections in RSV transmission in the
community.
Background
Respiratory syncytial virus (RSV) is the major viral cause
of lower respiratory tract infection in children world-
wide [1-4]. Our understanding of the mechanisms of
persistence and spread of the virus in the population is
fundamental to the development of appropriate control
methods. In this respect the process of recovery from
infection is of intrinsic interest. Primary RSV infection
predominantly arises in the first two years of life [5-10].
However, due to imperfect immunity RSV repeatedly
infects, probably throughout life [11,12]. Given that
most infections are therefore repeat infections, their role
in the overall transmission of the virus within a popula-
tion is potentially of fundamental importance, and
highly dependent upon the level and duration of shed-
ding [13]. Roughly 1 in 100 cases of infant primary RSV
infection result in hospitalisation and a far smaller
proportion in older ages and following re-infection
[5,14]. Hence, measurement of the infectivity of commu-
nity cases not found in the hospital setting is important;
particularly if severity is related to duration of shedding
as such cases are likely to be the main contributors to
transmission. It is recognised that immunocompromised
individuals can shed RSV for many weeks, and persis-
tent shedding may have significant impact on RSV per-
sistence and seasonal patterns [15].
It is therefore surprising that published estimates of
the duration of shedding of RSV are few. Studies of chil-
dren hospitalized with acute respiratory infection (ARI)
[16-19], provide estimates of shedding duration biased
towards infections causing severe disease and from a
narrow (young) age group. It has been shown that
greater severity of infection within in-patients results in
increased duration of shedding [17]. One study esti-
mated the duration of RSV shedding through home-
based monitoring of all individuals in 36 U.S. families
during a single epidemic [11]. A mean duration of 3.5-
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(range 1-36 days), with higher duration for children
under 2 years than for children under 16 years (9 vs. 3.9
days). Estimates, however, were not defined in relation
to past infection status. A second study of 97 U.S.
families following children under 4 years of age reported
over 70% of cultures positive up to 7 days post illness
onset, falling to less than 10% in week 2 and 3 [20]. No
evidence for a difference in shedding duration between
primary and re-infections was observed in this study
(there were only 16 re-infections). Studies of adults [21]
in the community show shedding to be of similar or
slightly shorter duration than shedding for children 1.6-
3.9 days (range 1-27). Despite the fact that the median
duration of RSV shedding tends to be of the order of
days, considerable variation exists: in the family studies
referred to earlier, 5-10% of individuals shed for more
than 14 days, and periods of shedding of 30-40 days
have been recorded[11,17,18,20].
In this paper we report on the duration of virus shed-
ding from RSV infected individuals within a family
cohort in a rural Kenyan community, in relation to
infection history, age and severity.
Methods
Study population and samples
The study was undertaken in Kilifi District, a rural
coastal area of Kenya, and forms part of an epidemiolo-
gical investigation of RSV through the intensive surveil-
lance of a birth cohort [4,14] and a household cohort
[11,12,22]. Infants numbering 635 were recruited at
birth or within two weeks of birth from January to June
2002 and from December 2002 to May 2003 and inten-
sively monitored for acute respiratory infections (ARI)
over three RSV epidemics. A sub-sample of 70 house-
h o l d s ,e a c hw i t ho n eo rm o r es i b l i n g so fb i r t hc o h o r t
children, was enrolled into a family study. All family
members were monitored for ARI for a period including
two RSV epidemics (Dec 2003-June 2004 and November
2004-March 2005) through weekly household visits dur-
ing epidemics and monthly otherwise, self referral to a
research out-patient clinic and admission to a paediatric
ward of the District hospital. Data on the onset of symp-
toms defined by history was recorded at presentation to
the research clinic. Nasal washings (NW) using a nasal
wash bulb method were collected from infants and elder
household siblings (<15 years of age; range 0-14) experi-
encing episodes of acute (rapid onset) respiratory illness,
whether mild (e.g. runny nose) or more severe. The pre-
sence or history of these symptoms in the preceding
week was used as a prompt for sample collection.
Respiratory disease severity was assigned as upper
respiratory tract infection (URTI), mild lower respiratory
tract infection (LRTI), or severe LRTI or very severe
LRTI as previously described [4]. Mild LRTI was defined
as a history of acute cough or difficulty in breathing and
fast breathing for age. Severe (inclusive of very severe)
LRTI was defined as a history of acute cough or diffi-
culty in breathing and one of more of the following: (1)
indrawing, (2) low oxygen saturation (<90%) by pulse
oxymetry or (3) inability to feed inclusive of prostration
or unconsciousness, the latter two conditions applying
only if accompanied by a clinical diagnosis of LRTI or
bronchiolitis. Samples were screened for RSV antigen by
a commercial direct immunofluorescent antibody test
(RSV DFA, Chemicon) [4]. Informed consent for partici-
pation in the study was obtained from each child’s guar-
dian. Ethical approval for the study was granted by the
KEMRI/National Ethical Review Committee, in Kenya
and Coventry Research Ethics Committee, in the UK.
Mothers of RSV positive children were asked to enrol
their children into the shedding study. We estimated the
sample size based on infection rates monitored from
previous epidemics (assumed to be 30%) [4], with the
expected result of approximately 100 primary cases and
100 re-infections from the family cohort. We estimated
that this would enable the detection of a 50% difference
in two rates (e.g. 1/9 days vs. 1/6 days for primary and
secondary infections) with 90% power at the 5% signifi-
cance level [23], even after stratification for one poten-
tial confounder (e.g. age class). Following the
identification of RSV infection (day 1), a further NW
was obtained as soon as possible, and thereafter sched-
uled for every 3 days up to day 14, thereafter after an
additional 7 and 14 days, and subsequently every 2
weeks up to 16 weeks. During follow up no further sam-
ples were taken after a single sample tested antigen
negative by DFA test.
Data analysis
Data were analyzed using Stata version 8.0 (Statacorp,
College Station, Texas, US). Time to recovery (end of
shedding) survival analysis (Cox regression) was used for
repeated measurements within the individual specific for
each episode of infection. We defined the null hypoth-
esis as an absence of association between the duration
of viral shedding and infection history, age or severity.
History of infection was defined as a previous positive
sample for children followed from birth and was other-
wise assumed for all children over 3 years (greater than
36 months) of age. Initially, an analysis of all records
was carried out using the start date for viral shedding i.
e. the first day of sampling as day 0. Subsequently, for
data records from research clinic visits where relevant
information was collected, the start date for viral shed-
ding was considered to coincide with the start of the
onset of symptoms defined by history taken at presenta-
tion to the research clinic with day 0 as the first day of
symptoms. The end of shedding was denoted by the
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used to test the proportionality assumption on which
the method is based and the models were found not to
violate the assumption. Shedding was assumed to start
on the day of the first positive sample (or on day of
onset of symptoms) with the end on the day of the first
negative test sample. We used the likelihood ratio test
to test the null hypothesis that two models are equally
supported by the data.
Results
A total of 193 RSV positive children, from 151 families,
were enrolled into the shedding study, of which 160
were birth cohort infants and 33 siblings. 192 negative
results (i.e. indicating cessation of shedding) were
observed. One child died in hospital before completing
the study and due to lack of further information is right
censored. For 120 children, the first positive sample was
also the last positive sample. The children were between
the ages of 2 and 164 months at recruitment into the
shedding study, 10.4% were less than 1 year while 70%
were 2 years of age or less. The median age of children
in the study was 21 months, and 46% were male. 3% of
all the children in the larger birth cohort had a birth
weight of <2.5 kg. Of the 193 RSV infections 165 were
classified as having an upper respiratory tract infection
(URTI), 20 as mild LRTI, 8 as severe LRTI, and none
with very severe LRTI. The frequency distribution of
days to cessation is shown in Fig. 1. The overall rate of
recovery (cessation of shedding) per day irrespective of
infection history, age and severity was 0.22/person/day
(95% CI 0.19-0.25) i.e. a mean duration of shedding
(reciprocal of rate of recovery) of 4.5 days (95%CI 4.0-
5.3), with a median duration of shedding for all children
of 4 days (IQR 2-6, range 1-14). The proportion of indi-
viduals with prior history of infection was 0.53 in chil-
dren with URTI compared with 0.5 and 0.25 in children
with severe LRTI and mild LRTI, respectively. Both the
URTI and mild LRTI disease categories had a higher
proportion of children in the older (≥18 months) age
group compared to the severe LRTI category. One hun-
dred and thirty six of 193 positives were from children
attending the research clinic and these records had data
on the number of days with symptoms based on history.
The average duration of shedding for this subset of chil-
dren was 7.69 days (95% CI 6.41-8.98). A comparison of
the two populations (clinic attendees and non-clinic
attendees) reveals that the ages of children who attended
the clinic and those seen at home were similar (t-test, P
= 0.1736). All children seen at home had an URTI
except for one child who had a severe LRTI and was
referred to hospital for admission. By comparison 21%
of children presenting to the clinic had a diagnosis of
mild or severe LRTI.
Shedding patterns in relation to gender
The rate of loss of infection did not differ significantly
between males and females (Table 1 &2; hazard ratio
(HR) 0.86; 95% CI 0.64-1.16).
Shedding patterns in relation to age
Children were grouped into four age classes: 0-11
months (10%), 12-17 months (19%), 18-23 months
(34%) and 24 months or more (37%). The median rate
of recovery was 4 days in all the age groups with inter-
quartile ranges of 3-5, 2-6, 3-6 and 2-5, for each age
group in ascending order. The duration of shedding did
not differ greatly between the four age groups as shown
i nT a b l e1 .U s i n gt h e0 - 1 1m o n t h sa g eg r o u pa st h e
reference group, the rate of recovery decreased by 9%
(HR 0.91; 95%CI 0.54-1.53) in 18-23 months age groups,
and increased by 1% (HR 1.01; 95% CI 0.57-1.76) and
8% (HR 1.08; 95%CI 0.65-1.80) in the 12-17 month and
in the 24+age group, respectively. None of these differ-
ences were significant (Table 2). Reclassfiying age into
two categories suggested a more rapid recovery in the
older (24 months and over) relative to the younger chil-
dren (Fig. 2). There was no evidence to suggest an
improved fit of the model after adjusting for past history
of infection (likelihood ratio test, P = 0.533).
Shedding patterns in relation to severity
The rate of recovery was faster for children with an
URTI as shown in Table 1 compared to those with mild
or severe LRTI. Those with an URTI shed virus for a
median of 4 days (IQR 2-6 days). Similarly, the severe
LRTI cases shed virus for a median of 4 days (IQR 4-6).
Those with mild LRTI shed virus for the longest period
with a median of 5 days (IQR 4-6). Cox regression, sug-
gested that relative to cases with URTI, the recovery
rate decreased by 31% (HR 0.69; 95%CI 0.42-1.14) and
18% (HR 0.82; 95%CI 0.38-1.80) for those with mild and
seveve LRTI, respectively (Table 2). These data are dis-
played graphically in Fig. 2 with the mild and severe
cases combined due to small number of cases with
severe LRTI. These results were not statistically signifi-
cant and the model adjusting for age and history of
infection did not improve the fit to the data (likelihood
ratio test, P = 0.2723).
Shedding patterns in relation to history of infection
Of the 193 children 77 had a known history of one or
more past RSV infections. These were all children who
had been followed up from birth. The mean duration of
shedding differed between those children who had never
been infected and those with prior history of infection;
4.9 (CI 4.1-5.8) days vs. 4.1 (CI 3.3-5.1) days (Table 1).
This study also included children who had been
recruited as household members of a birth cohort but
whose history of infection since birth was unknown. All
household children who were >36 months of age (19/33
birth cohort child siblings) at the time of enrollment
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duration of shedding between those children who had
never been infected and those with prior history of
infection after the revised assignment was 5.1 (CI 4.1-
5.8) days vs. 4.0 (CI 3.3-5.1) days (Table 1). The rate of
cessation of shedding was found to be significantly more
rapid in individals with prior infection history relative to
those without (HR is 1.37; 95%CI 1.01-1.86, P = 0.04
Table 2; Fig. 2), indicating that those with prior history
had a ~40% increased rate of recovery. The median
duration of shedding for the children with a previous
history of infection was 4 days (median age of child 23
m o n t h s )w h i l ef o rt h o s ew i t h o u tah i s t o r yo fi n f e c t i o n
the duration of shedding was 5 days (median age 20
months) with IQR of 2-5 and 3-7 days, respectively.
Adjusting for the effect of all the other variables
improved the fit to the data (likelihood ratio test, P =
0.044); this shows a significant effect of history even
when controlled for age group, gender and severity
(Table 2). However, these variables do not appear to
confound or alter the effect of history as the estimate
adjusted for these variables does not change significantly
(hazard ratio of 1.41 vs 1.37).
Shedding patterns in clinic attenders
For the subset of children presenting to the research
clinic for whom illness history was obtained a separate
Figure 1 Frequency of duration of RSV shedding.
Table 1 Rates of recovery from infection (cessation of shedding virus) per day estimated using survival analysis using
data from 192 RSV infected Kenyan children.
Feature Number Mean duration of shedding Lower CI Upper CI
History never infected 115 4.9 4.1 5.8
infected 77 4.1 3.3 5.1
sex Male 88 4.4 3.6 5.4
Female 104 4.7 3.9 5.7
Age group 0-11 months 21 4.4 2.9 6.7
12-17 months 35 4.9 3.5 6.8
18-23 months 65 4.9 3.9 6.3
24+ months 71 4.1 3.3 5.2
Severity URTI 165 4.4 3.8 5.1
Mild LRTI 20 5.6 3.6 8.8
Severe LRTI 7 5.2 2.5 10.8
Revised History
$ never infected 96 5.1 4.2 6.2
infected 96 4.0 3.3 4.9
$ Assumes children over 3 years (greater than 36 months old) have been previously infected.
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shedding among those children who had never been
infected and those with prior history of infection
(defined by antigen positive RSV detection or child age
>36 months) was 8.2 (CI 6.5-10.3) days compared to 7.0
(CI 5.5-8.8) days. The rate of cessation of shedding was
found to be more rapid in individuals with prior history
of infection relative to those without a history of infec-
tion (Adjusted HR is 1.43; 95%CI 0.997-2.051, P =
0.052), indicative of a 43% increased rate of recovery in
those children with prior history of infection.
Discussion
Studies that investigate the duration of RSV shedding
are few, especially for cases not resulting in hospital
admission, and there are no studies from a resource
poor setting. We followed up 193 children from 151
rural households on the coast of Kenya, estimating the
mean duration of shedding to be 4.5 (95%CI 4.0-5.3)
days ranging from a minimum of 1 day to a maximum
of 14 days. This study provides the first estimates of
shedding patterns in non-hospitalised community
acquired infections in relation to past history of infec-
tion adjusted for age, sex and severity of infection.
A key finding in our study is that while the recovery
from shedding was more rapid in children previously
infected, the rate was only 40% higher in these children.
Hence, we surmise that although primary infected chil-
dren shed longer, their total contributon of days shed-
ding virus within the community will be substantially
less than the cumulative days of virus shed by children
experiencing secondary infections, since due to repeated
reinfections, secondary infections are far more prevalent
than primary infections. A similar relationship, though
more exagerated, may be inferred from the family study
by Hall et al.[11] where longer shedding was observed
Table 2 Cox regression model results to examine factors independently associated with cessation of shedding in 192
RSV infected Kenyan children.
Feature* RR
& p-value Lower CI Upper CI
Revised history
$ infected 1.37 0.04 1.01 1.86
Sex Female 0.86 0.33 0.64 1.16
Age group 12-17 months 1.01 0.98 0.57 1.76
18-23 months 0.91 0.73 0.54 1.53
24+ months 1.08 0.78 0.65 1.80
Severity Mild LRTI 0.69 0.15 0.42 1.14
Severe LRTI 0.82 0.62 0.38 1.80
*baseline for each comparison is: no history of infection, male sex, 0-11 month age group and URTI severity.
&All estimates are adjusted for all other factors.
$Assumes children over 3 years (greater than 36 months old) have been previously infected.
Figure 2 Kaplan-Meier survivor function plots for cessation of sheddding of RSV in infected Kenyan children. Results are categorised by
age class (blue: 0-23 months; maroon: 24+ months) in Graph a, by infection history (blue: never infected; maroon: infected-significantly different;
log rank test p < 0.05 ) in Graph b, and by severity (blue: URTI; maroon: LRTI) in Graph c.
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tory of infection) than for children aged 2-16 years (9 vs
3.9 days). It is of interest that the study of Frank et al.
[20] involving approximatley 100 children found no dif-
ference in the duration of shedding between 32 primary
and 16 re-infections. The study involved children within
a very narrow age range (<4 years) which may explain
the lack of effect seen. Methodologically that study dif-
fered from the present in that samples were collected
from individuals irrespective of symptoms thus identify-
ing shedding prior to symptoms. While this would have
increased the average duration of shedding it seems
unlikely to have annulled a relationship with infection
history. Prolonged shedding of RSV enhances the possi-
bility of transmission and makes such individuals poten-
tial sources of community infection an important
consideration in the control and prevention of RSV
infection and disease in infants [15]. In our study only
two (1%) children shed virus for longer than 12 days.
No significant age-related difference in the rate of
recovery was observed in this study, which accords with
results reported by Wright et al. [25]. A plausible expla-
nation is that the duration of shedding is determined
more by immunity to infection than by a child’s age (or
physiology).
Evidence for a positive association between severity of
the infection and duration of shedding was inconclusive
in this study. Hospital based studies dealing with severe
disease have observed durations of shedding of approxi-
mately 7 days or more [17,18], which is longer than the
median 5 day duration of shedding for severe pneumo-
nia in this study. We expected to see a relationship
between severity and history of infection as resistance
derived from past infection might be expected to reduce
the severity of illness in those re-infections which do
occur. Such a relationship was shown by Glezen et al.
[5] who found that repeat infections with RSV were less
severe than primary infections. However, history of
infection did not appear to confound the relationship
between severity and duration of shedding.
Factoring into the analysis days with symptoms for the
children who presented to the clinic leads to an
increased duration of shedding from approximately 5
days to 8 days. However, this makes two assumptions:
First that recall of the number of days symptomatic is
reliable, for which we cannot be sure. Second, that indi-
viduals begin shedding virus from the start of symptoms
and that the symptoms are related to the RSV infection,
which seems reasonable (Frank et al., 1981). Inclusion of
days symptomatic, while increasing the estimated dura-
tion of shedding, does not alter the relationship between
duration and history of past RSV infection (although
statistically of borderline significance). The increased
duration of shedding when prior days of symptoms are
accounted for applies specifically to the more severe
cases identified on our study (i.e. those serious enough
to warrant clinic attendance). To what extent this
increase applies also to the majority of child infections
with less severe RSV who were sampled at home is not
clear, though we might expect those with milder symp-
toms to have infections of shorter duration.
There are several methodological issues that will have
resulted in the estimates reported here being minimum
estimates of shedding duration. First, the duration of
shedding may have been under-estimated by taking the
first negative test to indicate cessation of shedding, espe-
cially as sensitivity of DFA antigen detection is not per-
fect and if sensitivity decreases as duration increases,
due, for example, to decreasing viral load. Continued
sampling for at least one more round to assess the sen-
sitivity would have proved useful. Second, more sensitive
detection techniques such as PCR might be warranted -
however, it is less certain whether identification by PCR
relates more to viable virus compared with the DFA
diagnostic method used here; PCR has the limitation of
indicating presence, but not virus viability. Third, we
did not quantify the viral load in the samples. The quan-
tification of viral load might have epidemiological conse-
quences for transmission potential and has also been
shown to be associated with disease severity [26,27].
Fourth, the data will have been subject to left censoring,
i.e. exact start time of shedding was not observed. Stu-
dies that take samples irrespective of symptoms provide
more information, but are methodologically difficult to
implement [20]. We attempted an analysis of these data
by imputing a time at infection from data on time from
current infection to the last previous RSV negative DFA
result, but there is very little additional information to
improve the estimates from the simpler analyses
reported here. Lastly, we have assumed that all children
not followed up from birth who were over 36 months of
age have had a prior infection, an assumption well sup-
ported by the literature [5-10]. Other approaches to
detect infection history, for example examining changes
in titre of specific antibodies, present their own techni-
cal problems in terms of logistics and reliability but
should be considered for future studies.
Conclusion
In summary, information on the duration of shedding of
respiratory viruses in naturally infected persons that do
not result in hospitalization is important to our under-
standing of the transmission of infection. Our findings
will contribute to the development of transmission
dynamic models to investigate the impact of immuniza-
tion on the transmission dynamics of RSV. Specifically,
we demonstrate an association between the duration of
shedding and history of infection thus adding to the
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helping to quantify the relative contribution of primary
and secondary infections to overall infection transmis-
sion [28].
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